Abesamis, Alex Hagaiza C.

HRN: 19-50-31  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2025
CEFUROXIME 750MG (VIAL)
06/23/2025
06/29/2025
IV
570mg
Q8h
T/c Urinary Tract Infection
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: